Arch Therapeutics, Inc. (OTCMKTS:ARTH – Get Free Report)’s share price crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $0.50 and traded as low as $0.34. Arch Therapeutics shares last traded at $0.34, with a volume of 60,298 shares.
Arch Therapeutics Stock Up 49.8 %
The firm has a 50 day moving average price of $0.49 and a 200 day moving average price of $0.83.
Arch Therapeutics (OTCMKTS:ARTH – Get Free Report) last issued its quarterly earnings results on Monday, August 19th. The biotechnology company reported ($1.44) EPS for the quarter. The company had revenue of $0.03 million during the quarter.
Arch Therapeutics Company Profile
Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.
Featured Articles
- Five stocks we like better than Arch Therapeutics
- What is Short Interest? How to Use It
- Texas Roadhouse Stock Steering for New Highs This Year
- About the Markup Calculator
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Arch Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
